IRIS Accounts Production v23.1.0.753 08527568 director 1.6.22 31.5.23 31.5.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure085275682022-05-31085275682023-05-31085275682022-06-012023-05-31085275682021-05-31085275682021-06-012022-05-31085275682022-05-3108527568ns15:EnglandWales2022-06-012023-05-3108527568ns14:PoundSterling2022-06-012023-05-3108527568ns10:Director12022-06-012023-05-3108527568ns10:PrivateLimitedCompanyLtd2022-06-012023-05-3108527568ns10:SmallEntities2022-06-012023-05-3108527568ns10:AuditExemptWithAccountantsReport2022-06-012023-05-3108527568ns10:SmallCompaniesRegimeForDirectorsReport2022-06-012023-05-3108527568ns10:SmallCompaniesRegimeForAccounts2022-06-012023-05-3108527568ns10:FullAccounts2022-06-012023-05-310852756812022-06-012023-05-3108527568ns10:RegisteredOffice2022-06-012023-05-3108527568ns5:CurrentFinancialInstruments2023-05-3108527568ns5:CurrentFinancialInstruments2022-05-3108527568ns5:Non-currentFinancialInstruments2023-05-3108527568ns5:Non-currentFinancialInstruments2022-05-3108527568ns5:ShareCapital2023-05-3108527568ns5:ShareCapital2022-05-3108527568ns5:RetainedEarningsAccumulatedLosses2023-05-3108527568ns5:RetainedEarningsAccumulatedLosses2022-05-3108527568ns5:NetGoodwill2022-06-012023-05-3108527568ns5:IntangibleAssetsOtherThanGoodwill2022-06-012023-05-3108527568ns5:NetGoodwill2022-05-3108527568ns5:NetGoodwill2023-05-3108527568ns5:NetGoodwill2022-05-3108527568ns5:CostValuation2022-05-31
REGISTERED NUMBER: 08527568 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MAY 2023

FOR

PHARM MAK LIMITED

PHARM MAK LIMITED (REGISTERED NUMBER: 08527568)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Report of the Accountants 6

PHARM MAK LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MAY 2023







DIRECTOR: S Lau





REGISTERED OFFICE: 19 Edinburgh Drive
Staines-upon-Thames
Surrey
TW18 1PJ





REGISTERED NUMBER: 08527568 (England and Wales)





ACCOUNTANTS: Alchemy Financial Solutions Ltd
19 Edinburgh Drive
Staines - Upon - Thames
Surrey
TW18 1PJ

PHARM MAK LIMITED (REGISTERED NUMBER: 08527568)

BALANCE SHEET
31 MAY 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 375,498 375,498
Investments 5 2 2
375,500 375,500

CURRENT ASSETS
Cash at bank 40 49

CREDITORS
Amounts falling due within one year 6 83,591 82,991
NET CURRENT LIABILITIES (83,551 ) (82,942 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

291,949

292,558

CREDITORS
Amounts falling due after more than one
year

7

386,386

386,386
NET LIABILITIES (94,437 ) (93,828 )

CAPITAL AND RESERVES
Called up share capital 200 200
Retained earnings (94,637 ) (94,028 )
SHAREHOLDERS' FUNDS (94,437 ) (93,828 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

PHARM MAK LIMITED (REGISTERED NUMBER: 08527568)

BALANCE SHEET - continued
31 MAY 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 21 February 2024 and were signed by:





S Lau - Director


PHARM MAK LIMITED (REGISTERED NUMBER: 08527568)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2023

1. STATUTORY INFORMATION

Pharm Mak Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 0, is being amortised evenly over its estimated useful life of nil years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

PHARM MAK LIMITED (REGISTERED NUMBER: 08527568)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MAY 2023

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 June 2022
and 31 May 2023 375,498
NET BOOK VALUE
At 31 May 2023 375,498
At 31 May 2022 375,498

5. FIXED ASSET INVESTMENTS
Shares in
group
undertakings
£   
COST
At 1 June 2022
and 31 May 2023 2
NET BOOK VALUE
At 31 May 2023 2
At 31 May 2022 2

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Amounts owed to group undertakings 83,591 82,991

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2023 2022
£    £   
Other creditors 386,386 386,386

8. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is Mr Sui Lau and Mr Kin Mak by virtual their 100% shareholding.

PHARM MAK LIMITED

REPORT OF THE ACCOUNTANTS TO THE DIRECTOR OF
PHARM MAK LIMITED

The following reproduces the text of the report prepared for the director in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Director are not required to be filed with the Registrar of Companies.

As described on the Balance Sheet you are responsible for the preparation of the financial statements for the year ended 31 May 2023 set out on page nil and you consider that the company is exempt from an audit.

In accordance with your instructions, we have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and information and explanations supplied to us.






Alchemy Financial Solutions Ltd
19 Edinburgh Drive
Staines - Upon - Thames
Surrey
TW18 1PJ


Date: .............................................